Sepracor Inc.
(NASDAQ:SEPR)|
12.08 +0.26 (2.20%) Jan 08 - Close |
|
|
|
After-Hours 12.08 0.00 (0.00%) Thu, 8 Jan 2009 7:40 PM
- Compare SEPR with:
- View: Line | Candlestick
Company Profile
Sepracor Inc.
84 Waterford Drive
Marlborough, MA 01752
United States - Map
Phone: (508) 481-6700
Fax: (508) 357-7499
Website: www.sepracor.com
State of incorporation: Delaware
CEO: Adrian Adams
Employees: 2,277
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
Dev/mfr/mkt pharmaceutical and biopharmaceuticals
A research-based pharmaceutical company focused on discovering, developing and commercializing differentiated products that address markets and unmet medical needs and that are prescribed by primary care physicians and certain specialists.
Recent news for SEPR
-
Course shows companies what NOT to put in writing
Reuters - 12 hours ago
-
Dr. Reddy's settles patent dispute over Clarinex
AP - Dec 23 2008 at 12:59 ET
-
Zacks.com - Dec 18 2008 at 2:24 ET
-
Coverage initiated on Sepracor by Piper Jaffray
Briefing.com - Dec 16 2008 at 7:24 ET
-
This Just In: Upgrades and Downgrades
Motley Fool - Dec 12 2008 at 12:01 ET
-
Coverage initiated on Sepracor by Soleil
Briefing.com - Dec 11 2008 at 7:34 ET
-
Business Wire - Dec 03 2008 at 7:00 ET
-
Last month to switch to 'green' asthma inhalers
AP - Dec 01 2008 at 3:29 ET
-
Economic Impact Award winners feted
bizjournals.com - Nov 27 2008 at 9:05 ET
-
Sepracor shares fall as UBS cuts price target
AP - Nov 20 2008 at 1:20 ET
Member sentiment (?) Neutral
Top members owning SEPR
-
Top 17%
+6.88%
-
Top 17%
+6.87%
-
Top 18%
+6.57%
* Average monthly return vs. S&P 500